Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avenue Therapeutics, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Avenue Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Avenue Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is ATXI. The reporting company's CIK number is 1644963.
The total value of stock buying since 2005 is $63,447.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-10-09||Rosenwald Lindsay A Md||Buy||1,350||5.40||7,290|
|2017-10-06||Rosenwald Lindsay A Md||Buy||2,900||5.63||16,327|
|2017-10-05||Rosenwald Lindsay A Md||Buy||3,550||5.60||19,880|
|2017-10-04||Rosenwald Lindsay A Md||Buy||2,200||5.60||12,320|
Insider trading activities including stock purchases, stock sales, and option exercises of ATXI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Avenue Therapeutics, Inc. (symbol ATXI, CIK number 1644963) see the Securities and Exchange Commission (SEC) website.